Insider Scan

Scan

Insider Scan

Scan symbols 32
ABBVADBEAMDAMZNARMASANASMLAVGOBNTXCRMCRSPCRWDFTNTGOOGLINTCISRGLLYMETAMRNAMRVLMSFTNOWNTLANVDAPANWPLTRQCOMTMOTSLATSMVRTXZS
Watchlists 1
@insider-scan
raw scan snapshot — prices as of scan date, not live 60 rows · screens, not recommendations superseded by2026-04-26-insider-scanported fromresearch/classic/scans/_archive/2026-03-20-insider-scan.mdscan sluginsider-scansource typescan-archive

Insider universe under heavy selling pressure across the board — ASAN, TSLA, META, MSFT, and QCOM all approaching or deep in oversold, with LLY (RSI 30) and ABBV (RSI 27.6) both hitting capitulation-zone levels; ARM stands out as the lone strong-up outlier at RSI 63.7 on +10.9% 7D momentum.

Quick Snapshot

Signal Reading
Overall 🔴 RISK-OFF ACROSS UNIVERSE — Mega-cap and mid-cap names all under pressure; only ARM and MRVL holding positive momentum
Oversold / Near Oversold ABBV (RSI 27.6), LLY (RSI 30), MSFT (RSI 32.1), TSLA (RSI 31.4), META (RSI 32.2), QCOM (RSI 34.1), ASAN (RSI 31.6)
Outliers (Strong) ARM (RSI 63.7, +17.2% 3M), MRVL (RSI 54, strong-up trend), MRNA (+47.3% 3M)
Key observation This is a broad tech/healthcare/growth selloff — insiders who bought are now underwater across most positions

Price Table (Data as of 2026-03-20)

Stock Price RSI vs SMA20 7D% 30D% Trend Status Action
ASAN $6.66 31.6 -7.1% -5.3% -8.3% strong-down 🔴 Structural Down ❌ Avoid
TSLA $368.57 31.4 -7.5% -4.0% -10.5% down 🟢 Near Oversold 🔍 Watch
CRSP $46.40 36.8 -14.0% -4.5% -13.2% strong-down 🔴 Breakdown ❌ Avoid
AVGO $312.37 40.3 -4.3% -4.1% -6.1% down 🟡 Weakening 🔍 Watch
AMD $198.92 46.4 -0.7% +4.2% -0.6% weak-down 🟡 Neutral 🔍 Watch
CRM $194.46 46.0 -0.1% -1.1% +5.0% strong-down 🔴 Structural Down ⚠️ Avoid
ADBE $246.79 34.1 -5.9% -3.0% -4.6% strong-down 🔴 Breakdown ❌ Avoid
PLTR $149.74 49.5 +1.5% +2.5% +10.7% strong-down 🟡 Neutral 🔍 Watch
NOW $110.65 43.9 -1.9% -1.9% +6.1% strong-down 🔴 Structural Down ⚠️ Avoid
NVDA $173.85 38.8 -5.1% -3.0% -8.4% down 🟡 Weakening 🔍 Watch
META $592.22 32.2 -7.3% -3.2% -9.6% strong-down 🟢 Near Oversold 🔍 Watch
GOOGL $299.27 40.1 -2.3% +0.1% -4.9% weak-down 🟡 Neutral 🔍 Watch
AMZN $205.84 41.3 -2.4% -0.6% -2.0% strong-down 🟡 Neutral 🔍 Watch
MSFT $381.95 32.1 -4.2% -3.0% -3.9% strong-down 🟢 Near Oversold 🔍 Watch
ARM $132.82 63.7 +7.3% +10.9% +5.8% weak-up 🟢 Momentum 🔒 Hold
ASML $1,299.20 40.7 -6.8% -0.2% -11.6% weak-down 🟡 Weakening 🔍 Watch
TSM $327.69 39.1 -7.3% -0.8% -11.3% weak-down 🟡 Weakening 🔍 Watch
QCOM $130.18 34.1 -4.4% -1.2% -8.3% strong-down 🔴 Breakdown ❌ Avoid
MRVL $87.54 54.0 +3.1% -0.4% +10.1% strong-up 🟢 Outperforming 🔒 Hold
INTC $43.76 45.5 -3.6% +0.1% -0.8% weak-down 🟡 Neutral 🔍 Watch
CRWD $405.46 44.1 -0.8% -4.0% +4.3% strong-down 🔴 Structural Down ⚠️ Avoid
PANW $163.33 48.6 +2.4% +0.4% +9.8% strong-down 🟡 Neutral 🔍 Watch
ZS $151.62 38.8 -2.2% +0.6% -5.1% strong-down 🔴 Breakdown ❌ Avoid
FTNT $81.07 46.1 -0.7% -1.6% +1.3% weak-up 🟡 Neutral 🔍 Watch
LLY $903.48 30.0 -8.9% -7.8% -10.5% weak-down 🟢 Near Oversold 📈 Accumulate
ABBV $204.75 27.6 -8.9% -8.1% -8.9% down 🔴 Capitulation 📈 Accumulate
ISRG $475.47 38.8 -3.0% +0.3% -5.7% strong-down 🟡 Weakening 🔍 Watch
TMO $472.83 33.7 -4.7% -0.1% -7.4% down 🟡 Near Oversold 🔍 Watch
MRNA $51.39 51.4 -3.1% -2.8% +3.1% strong-up 🟢 Holding 🔒 Hold
VRTX $455.65 43.6 -3.9% -3.4% -4.5% weak-down 🟡 Neutral 🔍 Watch
NTLA $13.01 49.0 -3.6% +0.3% +2.9% strong-up 🟡 Neutral 🔍 Watch
BNTX $87.69 35.5 -11.2% — — — 🟡 Weakening 🔍 Watch

Tier Analysis

Tier 1 — Outperformers (Long Bias)

  • ARM — RSI 63.7, +10.9% 7D, +17.2% 3M, +7.3% above SMA20. The only name in the universe with genuine momentum. Weak-up trend despite death cross drag. Custom silicon / AI chip design thesis intact.
  • MRVL — RSI 54, strong-up trend, +10.1% 30D, +3.1% above SMA20. Golden cross. Custom ASICs catching a bid. Holding well against broad tech weakness.
  • MRNA — RSI 51.4, strong-up trend, +47.3% 3M, +58.3% above SMA200. Momentum play on pipeline developments.

Tier 2 — Oversold Quality Names (Potential Entry)

  • ABBV — RSI 27.6, -8.9% 30D. AbbVie has consistent dividend history, strong cash flows. At deep oversold with franchise intact (Skyrizi, Rinvoq). Quality entry level.
  • LLY — RSI 30.0, -10.5% 30D, -8.9% below SMA20. Eli Lilly at the oversold boundary. GLP-1 story intact long-term. Consolidating 3M weakness.
  • TSLA — RSI 31.4, -10.5% 30D. Approaching oversold. High-beta, polarizing, but insider universe watch name. Needs RSI floor before conviction.
  • META — RSI 32.2, -9.6% 30D, death cross. Ad market and AI investments intact; technically broken but fundamentals solid.
  • MSFT — RSI 32.1, -20.4% below SMA200, strong-down trend. Death cross. Cloud + AI story intact but structurally weak chart.

Tier 3 — Structural Downtrends (Avoid)

  • ASAN — RSI 31.6, -53.7% 3M, -47.2% below SMA200. Free fall. No floor visible.
  • ZS — RSI 38.8, -34.7% 3M, -41.3% below SMA200. Cybersecurity structural breakdown.
  • ADBE — RSI 34.1, -31.0% 3M, -26.4% below SMA200. Death cross; creative software monetization concerns.
  • QCOM — RSI 34.1, -24.8% 3M, -17.5% below SMA200. Death cross; mobile semi headwinds.
  • CRSP — RSI 36.8, -19.9% 3M, strong-down, death cross. Gene editing in structural correction.

Tier 4 — Neutral / Watching

Entry Zones

Stock Entry Zone RSI Conviction Notes
📈 ABBV $200–210 27.6 — Oversold HIGH Quality pharma; dividend compounder; legitimate oversold entry
📈 LLY $890–920 30.0 — At threshold MEDIUM-HIGH GLP-1 secular winner; consolidating +420% 5Y run
🔍 TSLA $355–375 31.4 — Approaching oversold MEDIUM Wait for RSI floor; volatile; no bottom signal yet
🔍 META $580–600 32.2 — Near oversold MEDIUM Death cross headwind; wait for trend stabilization
🔍 MSFT $375–390 32.1 — Near oversold MEDIUM Structurally weak; RSI entry ok but trend repair needed
🔍 NVDA $165–180 38.8 — Approaching MEDIUM Bouncing from SMA200; wait for RSI < 35 confirmation
🔒 ARM Hold / don't chase 63.7 — Elevated HIGH Only momentum name; hold if long, don't add here
❌ ASAN Avoid 31.6 NONE RSI doesn't matter when trend is strong-down; falling knife

Action Matrix

Action Stocks Why
📈 ACCUMULATE ABBV, LLY RSI < 30, quality names at legitimate oversold levels
🔒 HOLD ARM, MRVL, MRNA Momentum intact; outperforming universe
🔍 WATCH TSLA, META, MSFT, NVDA, GOOGL, AMZN, AVGO, TMO, ISRG, VRTX Near oversold or approaching; await RSI confirmation
⚠️ AVOID CRM, NOW, CRWD, PANW, FTNT Strong-down trend with partial bounces; don't buy the rallies
❌ AVOID ASAN, ZS, ADBE, QCOM, CRSP Structural downtrends; no floor signal

What Changed (vs 2026-03-12)

Stock 03-12 Est. 03-20 Change Note
ARM Weak RSI 63.7 ↑ Major Biggest mover in universe; +10.9% 7D
ABBV ~40 RSI 27.6 ↓ Capitulation New oversold signal; add to watchlist
LLY ~35 RSI 30.0 ↓ Approaching threshold GLP-1 leader hitting oversold
MRVL ~44 RSI 54, strong-up ↑ Custom ASICs holding vs broad sell-off
PLTR ~20 RSI 49.5 ↑ Recovered Bounced significantly from prior oversold
MRNA Weak RSI 51.4, strong-up ↑ +47.3% 3M momentum continues
CRSP Higher RSI 36.8, -13.2% 30D ↓ Gene editing deteriorating further

Key Discoveries

Discovery Implication
ABBV RSI 27.6 with dividend intact Best quality oversold signal in the universe; AbbVie is a dividend aristocrat at a discount
ARM RSI 63.7 while everything else sells off Custom silicon / AI chip design is where the smart money is hiding; only momentum name
MRVL strong-up trend in bear market Custom ASICs for hyperscalers decoupling from broad semi weakness
LLY RSI 30 at GLP-1 peak thesis Long-term secular winner at technical oversold; accumulate opportunity

Open Questions

  • Is ABBV's RSI 27.6 sustainable or will macro pressure push it below $200?
  • ARM +10.9% 7D — is this a real rotation into custom silicon or a short squeeze?
  • PLTR RSI recovery from ~20 to 49.5: is this a dead-cat bounce or genuine floor?
  • META death cross at RSI 32: Does ad market resilience justify contrarian entry here?

Scan universe: 32 stocks across mega-cap tech, semiconductors, cybersecurity, healthcare, and biotech tracked by insider activity monitors. Date: 2026-03-20.

10 events
DateTypeEvent
Mar 11 ScanInsider Activity Scan Mar 31 ScanInsider Universe Mar 20 ScanAI Scan Mar 26 ScanBargain Bin Mar 26 ScanInsider Universe Scan Mar 31 ScanTech Insider Buys Mar 11 ScanAI Scan Mar 11 ScanTech Insider Buys Scan Mar 10 ScanAI Scan Mar 31 ScanAI Scan

No direct external sources are attached to this read.